The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors?
When you’re heading up a fledgling biotech out to make a name for yourself in the middle of a wild industry boom, there’s one sure way to differentiate yourself that’s bound to attract universal nods.
It doesn’t involve lots of money — plenty of that going around — and it isn’t constrained by timelines.
You enlist some great scientists, and you put together a dream team of high-profile industry leaders to mentor you through the long and arduous process of drug development ahead.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.